BCM
OGN icon

Blume Capital Management’s Organon & Co OGN Stock Holding History

Blume Capital Management’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$68 Hold
5
– – ﹤0.01% 353
2026
Q1 		$30 Buy
+5
New +$38 ﹤0.01% 336
2022
Q3 		– Sell
-93
Closed -$3K – 325
2022
Q2 		$3K Buy
+93
New +$3.26K ﹤0.01% 290
2021
Q4 		– Sell
-40
Closed -$1K – 312
2021
Q3 		$1K Sell
40
-170
-81% -$5.44K ﹤0.01% 298
2021
Q2 		$6K Buy
+210
New +$6.91K ﹤0.01% 255

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Blume Capital Management's OGN Position: Q2 2026 in Review

Blume Capital Management held its Organon & Co (OGN) position steady in Q2 2026 at 5 shares worth $68. The position accounts for ﹤0.01% of the portfolio, ranked #353.

Blume Capital Management first reported a position in OGN in Q2 2021 and has held it in 5 quarters since. The position peaked at $6K in Q2 2021. 636 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Blume Capital Management held 5 shares of Organon & Co worth $68 as of Q2 2026.
  • Blume Capital Management left its Organon & Co share count unchanged in Q2 2026.
  • Organon & Co made up ﹤0.01% of Blume Capital Management's portfolio in Q2 2026, its #353 holding.
  • Blume Capital Management first reported a position in Organon & Co in Q2 2021 and has held it in 5 quarters since.
  • Blume Capital Management's Organon & Co position peaked at $6K in Q2 2021.
  • 636 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Blume Capital Management's 13F filing for Q2 2026, filed 27 Jul 2026.